Catalent | CTLT - 销售成本



销售成本 更改 日
Agilent USD 852M 19M 2025-12
AstraZeneca USD 3.27B 471M 2025-12
Bristol-Myers Squibb USD 4.92B 657M 2025-12
Bruker USD 528M 46.9M 2025-12
Centene USD 47.59B 831M 2025-12
Charles River Laboratories USD 722.27M 28.81M 2025-12
Cigna USD 63.37B 1.93B 2025-09
Danaher USD 2.87B 342M 2025-12
Dentsply International USD 518M 55M 2025-12
Elevance Health USD 38.07B 75M 2025-12
Eli Lilly USD 3.37B 363.7M 2025-12
Glaxosmithkline GBP 3.01B 853.01M 2025-09
Hologic USD 463.7M 5.1M 2025-12
Humana USD 26.54B 1.15B 2025-03
Illumina USD 400M 49M 2025-12
Intuitive Surgical USD 961.9M 119.2M 2025-12
IQVIA Holdings USD 3.24B 518M 2025-12
J&J USD 7.97B 689M 2025-12
Laboratory Of America USD 2.6B 56.8M 2025-12
Lonza CHF 2.28B 189M 2025-06
McKesson USD 102.47B 2.86B 2025-12
Merck EUR 2.29B 183M 2025-12
Merck USD 3.32B 531M 2025-12
Mettler Toledo International USD 473.97M 33.71M 2025-12
Novartis USD 3.54B 217M 2025-09
Pfizer USD 6.29B 2.12B 2025-12
Quest Diagnostics USD 1.93B 27M 2025-12
Repligen USD 94.08M 5.79M 2025-12
Revvity USD 350.4M 26.05M 2025-12
Roche Holding CHF 8.48B 4.61B 2025-12
Supernus Pharmaceuticals USD 47.53M 4.24M 2025-12
Thermo Fisher Scientific USD 7.58B 674M 2025-12
UnitedHealth USD 92.52B 920M 2025-09
Veradigm USD 68.49M 2.93M 2022-09
Waters USD 374.94M 47.13M 2025-12
West Pharmaceutical Services USD 501.1M 9.2M 2025-12